-
1
-
-
14044261316
-
What's wrong with our cancer models?
-
PMID:15688078
-
Kamb A. What's wrong with our cancer models? Nat Rev Drug Discov 2005; 4:161-5; PMID:15688078; http://dx.doi.org/10.1038/nrd1635
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 161-165
-
-
Kamb, A.1
-
2
-
-
33947596504
-
Why is cancer drug discovery so difficult?
-
PMID:17159925
-
Kamb A, Wee S, Lengauer C. Why is cancer drug discovery so difficult? Nat Rev Drug Discov 2007; 6:115-20; PMID:17159925; http://dx.doi.org/10.1038/ nrd2155
-
(2007)
Nat Rev Drug Discov
, vol.6
, pp. 115-120
-
-
Kamb, A.1
Wee, S.2
Lengauer, C.3
-
3
-
-
33746622984
-
Strategies for optimizing combinations of molecularly targeted anticancer agents
-
PMID:16883303
-
Dancey JE, Chen HX. Strategies for optimizing combinations of molecularly targeted anticancer agents. Nat Rev Drug Discov 2006; 5:649-59; PMID:16883303; http://dx.doi.org/10.1038/nrd2089
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 649-659
-
-
Dancey, J.E.1
Chen, H.X.2
-
4
-
-
33746544343
-
New paradigms in anticancer therapy: Targeting multiple signaling pathways with kinase inhibitors
-
PMID:16890796
-
Faivre S, Djelloul S, Raymond E. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Semin Oncol 2006; 33:407-20; PMID:16890796; http://dx.doi.org/10.1053/j.seminoncol.2006.04.005
-
(2006)
Semin Oncol
, vol.33
, pp. 407-420
-
-
Faivre, S.1
Djelloul, S.2
Raymond, E.3
-
5
-
-
63749101351
-
Targeting the EGFR and the PKB pathway in cancer
-
PMID:19216065
-
Klein S, Levitzki A. Targeting the EGFR and the PKB pathway in cancer. Curr Opin Cell Biol 2009; 21:185-93; PMID:19216065; http://dx.doi.org/10.1016/j. ceb.2008.12.006
-
(2009)
Curr Opin Cell Biol
, vol.21
, pp. 185-193
-
-
Klein, S.1
Levitzki, A.2
-
6
-
-
75149130051
-
Targeting the cancer kinome through polypharmacology
-
PMID:20094047
-
Knight ZA, Lin H, Shokat KM. Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 2010; 10:130-7; PMID:20094047; http://dx.doi.org/10.1038/nrc2787
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 130-137
-
-
Knight, Z.A.1
Lin, H.2
Shokat, K.M.3
-
7
-
-
77249176182
-
Rethinking screening
-
PMID:20154660
-
Kodadek T. Rethinking screening. Nat Chem Biol 2010; 6:162-5; PMID:20154660; http://dx.doi.org/10.1038/nchembio.303
-
(2010)
Nat Chem Biol
, vol.6
, pp. 162-165
-
-
Kodadek, T.1
-
8
-
-
77249164281
-
The (un)targeted cancer kinome
-
PMID:20154661
-
Fedorov O, Müller S, Knapp S. The (un)targeted cancer kinome. Nat Chem Biol 2010; 6:166-9; PMID:20154661; http://dx.doi.org/10.1038/nchembio.297
-
(2010)
Nat Chem Biol
, vol.6
, pp. 166-169
-
-
Fedorov, O.1
Müller, S.2
Knapp, S.3
-
9
-
-
0036632368
-
The phosphatidylinositol 3-Kinase AKT pathway in human cancer
-
PMID:12094235
-
Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 489-501
-
-
Vivanco, I.1
Sawyers, C.L.2
-
10
-
-
34250788809
-
AKT/PKB signaling: Navigating downstream
-
PMID:17604717
-
Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-74; PMID:17604717; http://dx.doi.org/10.1016/j.cell.2007.06.009
-
(2007)
Cell
, vol.129
, pp. 1261-1274
-
-
Manning, B.D.1
Cantley, L.C.2
-
11
-
-
53649103519
-
Metastasis and AKT activation
-
PMID:18818526
-
Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle 2008; 7:2991-6; PMID:18818526; http://dx.doi.org/10.4161/cc.7.19.6784
-
(2008)
Cell Cycle
, vol.7
, pp. 2991-2996
-
-
Qiao, M.1
Sheng, S.2
Pardee, A.B.3
-
12
-
-
33847314539
-
The phosphatidyl inositol 3-kinase signaling network: Implications for human breast cancer
-
PMID:17322919
-
Dillon RL, White DE, Muller WJ. The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 2007; 26:1338-45; PMID:17322919; http://dx.doi.org/10.1038/sj.onc.1210202
-
(2007)
Oncogene
, vol.26
, pp. 1338-1345
-
-
Dillon, R.L.1
White, D.E.2
Muller, W.J.3
-
13
-
-
34347269181
-
Roles of AKT signal in breast cancer
-
PMID:17485354
-
Liu W, Bagaitkar J, Watabe K. Roles of AKT signal in breast cancer. Front Biosci 2007; 12:4011-9; PMID:17485354; http://dx.doi.org/10.2741/2367
-
(2007)
Front Biosci
, vol.12
, pp. 4011-4019
-
-
Liu, W.1
Bagaitkar, J.2
Watabe, K.3
-
14
-
-
33746832533
-
Activation of PI3K/Akt signaling and hormone resistance in breast cancer
-
PMID:16755107
-
Tokunaga E, Kimura Y, Mashino K, Oki E, Kataoka A, Ohno S, et al. Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer 2006; 13:137-44; PMID:16755107; http://dx.doi.org/10.2325/jbcs.13.137
-
(2006)
Breast Cancer
, vol.13
, pp. 137-144
-
-
Tokunaga, E.1
Kimura, Y.2
Mashino, K.3
Oki, E.4
Kataoka, A.5
Ohno, S.6
-
15
-
-
66149141021
-
PTEN and the PI3-kinase pathway in cancer
-
PMID:18767981
-
Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009; 4:127-50; PMID:18767981; http://dx.doi.org/10.1146/annurev.pathol. 4.110807.092311
-
(2009)
Annu Rev Pathol
, vol.4
, pp. 127-150
-
-
Chalhoub, N.1
Baker, S.J.2
-
16
-
-
0035448879
-
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene
-
PMID:11544177
-
Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001; 15:2203-8; PMID:11544177; http://dx.doi.org/10.1101/ gad.913901
-
(2001)
Genes Dev
, vol.15
, pp. 2203-2208
-
-
Chen, W.S.1
Xu, P.Z.2
Gottlob, K.3
Chen, M.L.4
Sokol, K.5
Shiyanova, T.6
-
17
-
-
0035914388
-
Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice
-
PMID:11533044
-
Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001; 276:38349-52; PMID:11533044; http://dx.doi.org/10.1074/jbc.C100462200
-
(2001)
J Biol Chem
, vol.276
, pp. 38349-38352
-
-
Cho, H.1
Thorvaldsen, J.L.2
Chu, Q.3
Feng, F.4
Birnbaum, M.J.5
-
18
-
-
0035368548
-
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB β)
-
PMID:11387480
-
rd, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB β). Science 2001; 292:1728-31; PMID:11387480; http://dx.doi.org/10.1126/science.292.5522.1728
-
(2001)
Science
, vol.292
, pp. 1728-1731
-
-
Cho, H.1
Mu, J.2
Kim, J.K.3
Thorvaldsen, J.L.4
Chu, Q.W.5
Crenshaw III, E.B.6
-
19
-
-
20044382806
-
Role for Akt3/protein kinase Bgamma in attainment of normal brain size
-
PMID:15713641
-
Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, et al. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 2005; 25:1869-78; PMID:15713641; http://dx.doi.org/10.1128/MCB.25.5.1869- 1878.2005
-
(2005)
Mol Cell Biol
, vol.25
, pp. 1869-1878
-
-
Easton, R.M.1
Cho, H.2
Roovers, K.3
Shineman, D.W.4
Mizrahi, M.5
Forman, M.S.6
-
20
-
-
0037229714
-
Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of β1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells
-
PMID:12517798
-
Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, et al. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of β1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 2003; 63:196-206; PMID:12517798
-
(2003)
Cancer Res
, vol.63
, pp. 196-206
-
-
Arboleda, M.J.1
Lyons, J.F.2
Kabbinavar, F.F.3
Bray, M.R.4
Snow, B.E.5
Ayala, R.6
-
21
-
-
4944249733
-
Deregulated Akt3 activity promotes development of malignant melanoma
-
PMID:15466193
-
Stahl JM, Sharma A, Cheung M, Zimmerman M, Cheng JQ, Bosenberg MW, et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 2004; 64:7002-10; PMID:15466193; http://dx.doi.org/10.1158/0008-5472.CAN-04- 1399
-
(2004)
Cancer Res
, vol.64
, pp. 7002-7010
-
-
Stahl, J.M.1
Sharma, A.2
Cheung, M.3
Zimmerman, M.4
Cheng, J.Q.5
Bosenberg, M.W.6
-
22
-
-
0037203342
-
Ceramide in apoptosis: An overview and current perspectives
-
PMID:12531544
-
Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 2002; 1585:114-25; PMID:12531544; http://dx.doi.org/10.1016/S1388-1981(02)00331-1
-
(2002)
Biochim Biophys Acta
, vol.1585
, pp. 114-125
-
-
Pettus, B.J.1
Chalfant, C.E.2
Hannun, Y.A.3
-
23
-
-
3543114272
-
Biologically active sphingolipids in cancer pathogenesis and treatment
-
PMID:15286740
-
Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 2004; 4:604-16; PMID:15286740; http://dx.doi.org/10.1038/nrc1411
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 604-616
-
-
Ogretmen, B.1
Hannun, Y.A.2
-
24
-
-
33845294390
-
A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death
-
PMID:17161984
-
Taha TA, Mullen TD, Obeid LM. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 2006; 1758:2027-36; PMID:17161984; http://dx.doi.org/10.1016/j.bbamem.2006.10.018
-
(2006)
Biochim Biophys Acta
, vol.1758
, pp. 2027-2036
-
-
Taha, T.A.1
Mullen, T.D.2
Obeid, L.M.3
-
25
-
-
0035374461
-
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells
-
PMID:11278592
-
Morales-Ruiz M, Lee MJ, Zöllner S, Gratton JP, Scotland R, Shiojima I, et al. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 2001; 276:19672-7; PMID:11278592; http://dx.doi.org/10.1074/ jbc.M009993200
-
(2001)
J Biol Chem
, vol.276
, pp. 19672-19677
-
-
Morales-Ruiz, M.1
Lee, M.J.2
Zöllner, S.3
Gratton, J.P.4
Scotland, R.5
Shiojima, I.6
-
26
-
-
0142105397
-
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation
-
PMID:14532121
-
Pitson SM, Moretti PA, Zebol JR, Lynn HE, Xia P, Vadas MA, et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 2003; 22:5491-500; PMID:14532121; http://dx.doi.org/10.1093/emboj/cdg540
-
(2003)
EMBO J
, vol.22
, pp. 5491-5500
-
-
Pitson, S.M.1
Moretti, P.A.2
Zebol, J.R.3
Lynn, H.E.4
Xia, P.5
Vadas, M.A.6
-
27
-
-
0033839592
-
Human acid ceramidase is overexpressed but not mutated in prostate cancer
-
PMID:10959093
-
Seelan RS, Qian C, Yokomizo A, Bostwick DG, Smith DI, Liu W. Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer 2000; 29:137-46; PMID:10959093; http://dx.doi.org/10.1002/ 1098-2264(2000)9999:9999〈::AID-GCC1018〉3.0.CO;2-E
-
(2000)
Genes Chromosomes Cancer
, vol.29
, pp. 137-146
-
-
Seelan, R.S.1
Qian, C.2
Yokomizo, A.3
Bostwick, D.G.4
Smith, D.I.5
Liu, W.6
-
28
-
-
42549100356
-
The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy
-
PMID:17881906
-
Saad AF, Meacham WD, Bai A, Anelli V, Elojeimy S, Mahdy AE, et al. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy. Cancer Biol Ther 2007; 6:1455-60; PMID:17881906; http://dx.doi.org/10.4161/cbt.6.9.4623
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 1455-1460
-
-
Saad, A.F.1
Meacham, W.D.2
Bai, A.3
Anelli, V.4
Elojeimy, S.5
Mahdy, A.E.6
-
29
-
-
33845296931
-
Acid ceramidase and human disease
-
PMID:17064658
-
Park JH, Schuchman EH. Acid ceramidase and human disease. Biochim Biophys Acta 2006; 1758:2133-8; PMID:17064658; http://dx.doi.org/10.1016/j.bbamem.2006. 08.019
-
(2006)
Biochim Biophys Acta
, vol.1758
, pp. 2133-2138
-
-
Park, J.H.1
Schuchman, E.H.2
-
30
-
-
52449089092
-
Molecular targeting of acid ceramidase: Implications to cancer therapy
-
PMID:18691012
-
Zeidan YH, Jenkins RW, Korman JB, Liu X, Obeid LM, Norris JS, et al. Molecular targeting of acid ceramidase: implications to cancer therapy. Curr Drug Targets 2008; 9:653-61; PMID:18691012; http://dx.doi.org/10.2174/ 138945008785132358
-
(2008)
Curr Drug Targets
, vol.9
, pp. 653-661
-
-
Zeidan, Y.H.1
Jenkins, R.W.2
Korman, J.B.3
Liu, X.4
Obeid, L.M.5
Norris, J.S.6
-
31
-
-
38449123215
-
Acid ceramidase inhibition: A novel target for cancer therapy
-
PMID:17981711
-
Liu X, Elojeimy S, Turner LS, Mahdy AE, Zeidan YH, Bielawska A, et al. Acid ceramidase inhibition: a novel target for cancer therapy. Front Biosci 2008; 13:2293-8; PMID:17981711; http://dx.doi.org/10.2741/2843
-
(2008)
Front Biosci
, vol.13
, pp. 2293-2298
-
-
Liu, X.1
Elojeimy, S.2
Turner, L.S.3
Mahdy, A.E.4
Zeidan, Y.H.5
Bielawska, A.6
-
32
-
-
84865546284
-
Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B
-
PMID:22322590
-
Beckham TH, Lu P, Cheng JC, Zhao D, Turner LS, Zhang X, et al. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. Int J Cancer 2012; 131:2034-43; PMID:22322590; http://dx.doi.org/10.1002/ijc.27480
-
(2012)
Int J Cancer
, vol.131
, pp. 2034-2043
-
-
Beckham, T.H.1
Lu, P.2
Cheng, J.C.3
Zhao, D.4
Turner, L.S.5
Zhang, X.6
-
33
-
-
0035863411
-
AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells
-
PMID:11212254
-
Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 2001; 61:589-93; PMID:11212254
-
(2001)
Cancer Res
, vol.61
, pp. 589-593
-
-
Tanno, S.1
Tanno, S.2
Mitsuuchi, Y.3
Altomare, D.A.4
Xiao, G.H.5
Testa, J.R.6
-
34
-
-
77953001932
-
AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion
-
PMID:20514445
-
Zhang J, Han L, Zhang A, Wang Y, Yue X, You Y, et al. AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion. Oncol Rep 2010; 24:65-72; PMID:20514445
-
(2010)
Oncol Rep
, vol.24
, pp. 65-72
-
-
Zhang, J.1
Han, L.2
Zhang, A.3
Wang, Y.4
Yue, X.5
You, Y.6
-
35
-
-
34548266099
-
AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines
-
PMID:17426444
-
Koseoglu S, Lu Z, Kumar C, Kirschmeier P, Zou J. AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biol Ther 2007; 6:755-62; PMID:17426444; http://dx.doi.org/10.4161/cbt.6.5.3995
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 755-762
-
-
Koseoglu, S.1
Lu, Z.2
Kumar, C.3
Kirschmeier, P.4
Zou, J.5
-
36
-
-
77957833800
-
The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane
-
PMID:20489726
-
Berndt N, Yang H, Trinczek B, Betzi S, Zhang Z, Wu B, et al. The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane. Cell Death Differ 2010; 17:1795-804; PMID:20489726; http://dx.doi.org/10.1038/cdd.2010.63
-
(2010)
Cell Death Differ
, vol.17
, pp. 1795-1804
-
-
Berndt, N.1
Yang, H.2
Trinczek, B.3
Betzi, S.4
Zhang, Z.5
Wu, B.6
-
37
-
-
77954615408
-
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo
-
PMID:20571069
-
Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, et al. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther 2010; 9:1956-67; PMID:20571069; http://dx.doi.org/10.1158/1535-7163. MCT-09-1012
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 1956-1967
-
-
Hirai, H.1
Sootome, H.2
Nakatsuru, Y.3
Miyama, K.4
Taguchi, S.5
Tsujioka, K.6
-
38
-
-
0035114217
-
Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer
-
PMID:11221856
-
Selzner M, Bielawska A, Morse MA, Rüdiger HA, Sindram D, Hannun YA, et al. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 2001; 61:1233-40; PMID:11221856
-
(2001)
Cancer Res
, vol.61
, pp. 1233-1240
-
-
Selzner, M.1
Bielawska, A.2
Morse, M.A.3
Rüdiger, H.A.4
Sindram, D.5
Hannun, Y.A.6
-
39
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
PMID:6382953
-
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22:27-55; PMID:6382953; http://dx.doi.org/10.1016/0065-2571(84)90007-4
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
40
-
-
33748794547
-
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
-
PMID:16968952
-
Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58:621-81; PMID:16968952; http://dx.doi.org/10.1124/pr.58.3.10
-
(2006)
Pharmacol Rev
, vol.58
, pp. 621-681
-
-
Chou, T.C.1
-
41
-
-
0033911968
-
Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels
-
PMID:10880954
-
López-Marure R, Ventura JL, Sánchez L, Montaño LF, Zentella A. Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels. Eur J Biochem 2000; 267:4325-33; PMID:10880954; http://dx.doi.org/10.1046/j.1432-1327.2000.01436.x
-
(2000)
Eur J Biochem
, vol.267
, pp. 4325-4333
-
-
López-Marure, R.1
Ventura, J.L.2
Sánchez, L.3
Montaño, L.F.4
Zentella, A.5
-
42
-
-
0037030465
-
Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells
-
PMID:12037683
-
von Haefen C, Wieder T, Gillissen B, Stärck L, Graupner V, Dörken B, et al. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 2002; 21:4009-19; PMID:12037683; http://dx.doi.org/10.1038/sj.onc.1205497
-
(2002)
Oncogene
, vol.21
, pp. 4009-4019
-
-
Von Haefen, C.1
Wieder, T.2
Gillissen, B.3
Stärck, L.4
Graupner, V.5
Dörken, B.6
-
43
-
-
0027202552
-
Ceramide activates heterotrimeric protein phosphatase 2A
-
PMID:8393446
-
Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993; 268:15523-30; PMID:8393446
-
(1993)
J Biol Chem
, vol.268
, pp. 15523-15530
-
-
Dobrowsky, R.T.1
Kamibayashi, C.2
Mumby, M.C.3
Hannun, Y.A.4
-
44
-
-
0033575310
-
Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid
-
PMID:10400653
-
Chalfant CE, Kishikawa K, Mumby MC, Kamibayashi C, Bielawska A, Hannun YA. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem 1999; 274:20313-7; PMID:10400653; http://dx.doi.org/10.1074/jbc. 274.29.20313
-
(1999)
J Biol Chem
, vol.274
, pp. 20313-20317
-
-
Chalfant, C.E.1
Kishikawa, K.2
Mumby, M.C.3
Kamibayashi, C.4
Bielawska, A.5
Hannun, Y.A.6
-
45
-
-
0037066727
-
De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1
-
PMID:11801602
-
Chalfant CE, Rathman K, Pinkerman RL, Wood RE, Obeid LM, Ogretmen B, et al. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 2002; 277:12587-95; PMID:11801602; http://dx.doi.org/10.1074/jbc.M112010200
-
(2002)
J Biol Chem
, vol.277
, pp. 12587-12595
-
-
Chalfant, C.E.1
Rathman, K.2
Pinkerman, R.L.3
Wood, R.E.4
Obeid, L.M.5
Ogretmen, B.6
-
46
-
-
1542723736
-
The structural requirements for ceramide activation of serine-threonine protein phosphatases
-
PMID:14657198
-
Chalfant CE, Szulc Z, Roddy P, Bielawska A, Hannun YA. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J Lipid Res 2004; 45:496-506; PMID:14657198; http://dx.doi.org/10.1194/jlr. M300347-JLR200
-
(2004)
J Lipid Res
, vol.45
, pp. 496-506
-
-
Chalfant, C.E.1
Szulc, Z.2
Roddy, P.3
Bielawska, A.4
Hannun, Y.A.5
-
47
-
-
0029942186
-
Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors
-
PMID:8650155
-
Andjelkovi M, Jakubowicz T, Cron P, Ming XF, Han JW, Hemmings BA. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci USA 1996; 93:5699-704; PMID:8650155; http://dx.doi.org/10.1073/pnas.93.12.5699
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 5699-5704
-
-
Andjelkovi, M.1
Jakubowicz, T.2
Cron, P.3
Ming, X.F.4
Han, J.W.5
Hemmings, B.A.6
-
48
-
-
4544314719
-
Protein phosphatase 2A negatively regulates Akt (protein kinase B) activity in 3T3-L1 adipocytes
-
PMID:15367694
-
Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, et al. Protein phosphatase 2A negatively regulates Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 2004; 24:8778-89; PMID:15367694; http://dx.doi.org/10. 1128/MCB.24.19.8778-8789.2004
-
(2004)
Mol Cell Biol
, vol.24
, pp. 8778-8789
-
-
Ugi, S.1
Imamura, T.2
Maegawa, H.3
Egawa, K.4
Yoshizaki, T.5
Shi, K.6
-
49
-
-
34249291096
-
The tumor suppressor PP2A Abeta regulates the RalA GTPase
-
PMID:17540176
-
Sablina AA, Chen W, Arroyo JD, Corral L, Hector M, Bulmer SE, et al. The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 2007; 129:969-82; PMID:17540176; http://dx.doi.org/10.1016/j.cell.2007.03.047
-
(2007)
Cell
, vol.129
, pp. 969-982
-
-
Sablina, A.A.1
Chen, W.2
Arroyo, J.D.3
Corral, L.4
Hector, M.5
Bulmer, S.E.6
-
50
-
-
58049199390
-
Deactivation of sphingosine kinase 1 by protein phosphatase 2A
-
PMID:18852266
-
Barr RK, Lynn HE, Moretti PA, Khew-Goodall Y, Pitson SM. Deactivation of sphingosine kinase 1 by protein phosphatase 2A. J Biol Chem 2008; 283:34994-5002; PMID:18852266; http://dx.doi.org/10.1074/jbc.M804658200
-
(2008)
J Biol Chem
, vol.283
, pp. 34994-35002
-
-
Barr, R.K.1
Lynn, H.E.2
Moretti, P.A.3
Khew-Goodall, Y.4
Pitson, S.M.5
-
51
-
-
0033575320
-
Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
-
PMID:10400650
-
Ruvolo PP, Deng X, Ito T, Carr BK, May WS. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 1999; 274:20296-300; PMID:10400650; http://dx.doi.org/10.1074/jbc.274.29.20296
-
(1999)
J Biol Chem
, vol.274
, pp. 20296-20300
-
-
Ruvolo, P.P.1
Deng, X.2
Ito, T.3
Carr, B.K.4
May, W.S.5
-
52
-
-
33745812349
-
Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation
-
PMID:16679323
-
Xin M, Deng X. Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation. J Biol Chem 2006; 281:18859-67; PMID:16679323; http://dx.doi.org/10.1074/jbc.M512543200
-
(2006)
J Biol Chem
, vol.281
, pp. 18859-18867
-
-
Xin, M.1
Deng, X.2
-
54
-
-
0031172801
-
Constitutively active protein phosphatase 1α causes Rb-dependent G1 arrest in human cancer cells
-
PMID:9197238
-
Berndt N, Dohadwala M, Liu CWY. Constitutively active protein phosphatase 1α causes Rb-dependent G1 arrest in human cancer cells. Curr Biol 1997; 7:375-86; PMID:9197238; http://dx.doi.org/10.1016/S0960-9822(06)00185-0
-
(1997)
Curr Biol
, vol.7
, pp. 375-386
-
-
Berndt, N.1
Dohadwala, M.2
Liu, C.W.Y.3
-
55
-
-
0035959632
-
Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein
-
PMID:11593419
-
Wang RH, Liu CWY, Avramis VI, Berndt N. Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 2001; 20:6111-22; PMID:11593419; http://dx.doi.org/10.1038/sj.onc.1204829
-
(2001)
Oncogene
, vol.20
, pp. 6111-6122
-
-
Wang, R.H.1
Liu, C.W.Y.2
Avramis, V.I.3
Berndt, N.4
-
56
-
-
0342657806
-
Protein phosphatase 1α is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis
-
PMID:10811615
-
Ayllón V, Martínez-A C, García A, Cayla X, Rebollo A. Protein phosphatase 1α is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J 2000; 19:2237-46; PMID:10811615; http://dx.doi.org/10.1093/emboj/19.10.2237
-
(2000)
EMBO J
, vol.19
, pp. 2237-2246
-
-
Ayllón, V.1
Martínez-A, C.2
García, A.3
Cayla, X.4
Rebollo, A.5
-
57
-
-
33947599080
-
A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis
-
PMID:17274640
-
Flores-Delgado G, Liu CWY, Sposto R, Berndt N. A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis. J Proteome Res 2007; 6:1165-75; PMID:17274640; http://dx.doi.org/10.1021/pr060504h
-
(2007)
J Proteome Res
, vol.6
, pp. 1165-1175
-
-
Flores-Delgado, G.1
Liu, C.W.Y.2
Sposto, R.3
Berndt, N.4
-
58
-
-
33746892660
-
Identification of PP1α as a caspase-9 regulator in IL-2 deprivation-induced apoptosis
-
PMID:16888006
-
Dessauge F, Cayla X, Albar JP, Fleischer A, Ghadiri A, Duhamel M, et al. Identification of PP1α as a caspase-9 regulator in IL-2 deprivation-induced apoptosis. J Immunol 2006; 177:2441-51; PMID:16888006
-
(2006)
J Immunol
, vol.177
, pp. 2441-2451
-
-
Dessauge, F.1
Cayla, X.2
Albar, J.P.3
Fleischer, A.4
Ghadiri, A.5
Duhamel, M.6
-
59
-
-
77955711839
-
Protein phosphatase-1 regulates Akt1 signal transduction pathway to control gene expression, cell survival and differentiation
-
PMID:20186153
-
Xiao L, Gong LL, Yuan D, Deng M, Zeng XM, Chen LL, et al. Protein phosphatase-1 regulates Akt1 signal transduction pathway to control gene expression, cell survival and differentiation. Cell Death Differ 2010; 17:1448-62; PMID:20186153; http://dx.doi.org/10.1038/cdd.2010.16
-
(2010)
Cell Death Differ
, vol.17
, pp. 1448-1462
-
-
Xiao, L.1
Gong, L.L.2
Yuan, D.3
Deng, M.4
Zeng, X.M.5
Chen, L.L.6
-
60
-
-
21444433243
-
Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities
-
PMID:15713677
-
Wang D-A, Sebti SM. Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities. J Biol Chem 2005; 280:19243-9; PMID:15713677; http://dx.doi.org/10.1074/jbc.M411472200
-
(2005)
J Biol Chem
, vol.280
, pp. 19243-19249
-
-
Wang, D.-A.1
Sebti, S.M.2
|